Aims Stent underexpansion and malapposition are associated with adverse outcomes following percutaneous coronary intervention, but detection and treatment can be challenging in the presence of extensive coronary artery calcification. Frequency domain optical coherence tomography (FD-OCT) is a novel intravascular imaging technique with greater spatial resolution than intravascular ultrasound (IVUS) but its role in the presence of extensive coronary calcification remains unclear. We sought to determine the utility of FD-OCT compared to IVUS imaging to guide percutaneous coronary intervention in patients with severe calcific coronary artery disease.
Methods 18 matched IVUS and FD-OCT examinations were evaluated following coronary stent implantation in 12 patients (10 male; mean age 70±7 years) undergoing rotational atherectomy for symptomatic calcific coronary artery disease.
Results In-stent luminal areas were smaller (minimum in-stent area 6.77±2.18 vs 7.19±2.62 mm2, p<0.05), while reference lumen dimensions were similar with FD-OCT compared with IVUS. Stent malapposition was detected in all patients by FD-OCT and in 10 patients by IVUS. The extent of stent malapposition detected was greater (20% vs 6%, p<0.001) with FD-OCT compared to IVUS. Postdilation increased the in-stent luminal area (minimum in-stent area: 8.15±1.90 vs 7.30±1.62 mm2, p<0.05) and reduced the extent of stent malapposition (19% vs 34%, p<0.005) when assessed by FD-OCT, but not IVUS.
Conclusions Acute stent malapposition occurs frequently in patients with calcific coronary disease undergoing rotational atherectomy and stent implantation. In the presence of extensive coronary artery calcification, FD-OCT affords enhanced stent visualisation and detection of malapposition, facilitating improved postdilation stent apposition and minimal luminal areas.
Trial Registration number NCT02065102.
Statistics from Altmetric.com
What is already known about this subject?
Stent malapposition and underexpansion are major risk factors for stent thrombosis and restenosis.
Intravascular imaging using ultrasound is useful to help identify stent malapposition and underexpansion and facilitates optimal stent placement.
The presence of extensive calcification limits the value of intravascular ultrasound reflecting the ultrasound waves and causing artefacts.
Optical coherence tomography is a novel intravascular imaging modality with 10-fold greater axial resolution than intravascular ultrasound.
It is not yet clear whether optical coherence tomography is superior to intravascular ultrasound in the presence of extensive vascular calcification.
What does this study add?
Coronary stent malapposition and underexpansion are common in patients with extensive vascular calcification undergoing percutaneous coronary intervention.
Optical coherence tomography is superior to intravascular ultrasound in the detection of stent underexpansion and malapposition in patients with extensive coronary artery calcification.
Stent postdilation reduced the extent of stent malapposition as assessed by optical coherence tomography.
How might this impact on clinical practice?
Choosing the most appropriate intravascular imaging modality in patients with extensive coronary artery calcification should facilitate the detection of stent underexpansion and malapposition, permit optimal stent implantation and, ultimately reduce the risk of stent thrombosis and restenosis.
Ensuring adequate coronary stent expansion and apposition at implantation are key factors in the prevention of in-stent restenosis and stent thrombosis.1–4 This can be challenging in patients with extensive coronary artery calcification where vascular calcification may limit equipment delivery, lesion preparation and ultimately, stent expansion and apposition to the vessel wall. The presence of extensive vascular calcification also limits angiographic visualisation impairing lesion assessment and detection of stent underexpansion and malapposition.
Intravascular ultrasound (IVUS) imaging is often used in conjunction with fluoroscopy to assess coronary stent implantation and guide percutaneous coronary intervention.5 However, ultrasound itself penetrates calcium poorly and this, combined with the potential for artefact, such as reverberation or reflection,6 limits the value of IVUS in the assessment of heavily calcified coronary arteries.
Fourier domain optical coherence tomography (FD-OCT) is a novel near-infrared intravascular imaging modality with ∼10-fold greater axial resolution (∼15 μm) than IVUS.7 ,8 Assessment of coronary artery dimensions by FD-OCT is accurate9 and reproducible.10 Postmortem data11 ,12 and case reports suggest that FD-OCT may afford enhanced visualisation in heavily calcified vessels when compared to IVUS,13 ,14 but this hypothesis remains to be tested systematically in a clinical study. The aim of this study was to compare FD-OCT with IVUS imaging in patients with extensive coronary artery calcification undergoing rotational atherectomy and coronary stent implantation.
Twelve patients undergoing percutaneous coronary intervention with adjunctive rotational atherectomy for undilatable calcific coronary artery disease at the Edinburgh Heart Centre were enrolled. Rotational atherectomy was performed using the Rotablator (Boston Scientific, Fremont, California, USA) and conventional techniques.15 Operators were encouraged to use a maximum burr/vessel ratio of 0.5 and rotational burr speed ranged between 160 000 and 190 000 rotations per minute. Intracoronary verapamil was administered during rotablation and temporary pacing wires were only inserted when clinically indicated. Operators were encouraged but not mandated to postdilate with a non-compliant balloon matched at least 1:1 with the proximal reference vessel. Patients were only included in the postdilation analysis if IVUS and FD-OCT data were available.
All patients were loaded and established on maintenance dose aspirin (75 mg) and clopidogrel (75 mg) prior to the procedure. Unfractionated heparin was administered as an initial bolus of 70 IU/kg with additional heparin being administered as guided by the activated clotting time (target 250–300 s). This study was performed with the approval of the West of Scotland Research Ethics Committee and written informed consent was obtained from all patients.
Imaging acquisition and analysis
In all patients, paired FD-OCT and IVUS automated pullback assessments were performed immediately following coronary stent implantation. In six patients, further paired FD-OCT and IVUS pullbacks were obtained immediately following high-pressure postdilation of the stent. Intracoronary nitroglycerin (200 μg) was administered immediately prior to each imaging pullback. Imaging data were stored digitally and analysed offline.
IVUS imaging was performed using a 40 MHz Atlantis SR Pro catheter (Boston Scientific, Fremont, California, USA) and an automated pullback at 0.5 mm/s to include the stented segment and at least 5 mm reference at either end.
Optical coherence tomography
Fourier domain OCT was performed using a FastView OFDI imaging catheter (Terumo, Tokyo, Japan) with an automated pullback at 20 mm/s. Intracoronary injection of undiluted X-ray contrast medium (omnipaque 300) at 4–5 mL/s was used to achieve a blood-free field of view.
Cross-sectional images were evaluated by two experienced operators using validated software (Analyze 11.0, Mayo Clinic, Minnesota, USA). Luminal areas and diameters were assessed at 0.15 mm intervals. Matched stented segments were defined for IVUS and FD-OCT images using proximal and distal stent edges and side branches as reference landmarks.
Malapposition detected by IVUS was defined as clear separation with visible blood speckle between at least one stent strut and the vessel wall.16 Malapposition detected by FD-OCT was defined as a distance between stent strut and vessel wall (chord length) of >1.5 times the manufacturers stated stent strut thickness. For IVUS and FD-OCT, 360° chords were generated based on the identified lumen and stent contours to identify the per cent of stent perimeter identified as malapposed and the maximum malapposition area. Given the thickness of each cross-sectional slice and the total number of analysed slices containing circumferential stent, we calculated the amount of malapposed stent expressed as a percentage of the total stent surface area for each patient.
Statistical analysis was performed using Graph Pad Prism 6. Data are expressed as mean±SD, median (range) or n (%) as appropriate. Between and within comparisons for matched IVUS and FD-OCT data were made using paired t test and further examined by correlation analysis and Bland-Altman plots. Two-sided p<0.05 was taken as statistical significance.
Eighteen paired IVUS and FD-OCT pullbacks were performed in 12 patients. In six patients, paired IVUS and FD-OCT pullbacks performed immediately following stent implantation and following stent postdilation were available. Patients were predominantly male with a mean age of 70 years (table 1) and principally received a single long drug-eluting stent following rotablation (table 2).
Reference lumen areas were similar but in-stent luminal areas as determined by FD-OCT were smaller (minimum in-stent luminal area: 6.77±2.18 vs 7.19±2.62 mm2, p<0.05) when compared to IVUS (tables 2 and 3). There was a good correlation between FD-OCT and IVUS measurements (minimum luminal diameter, r=0.95, p<0.0001; and minimum luminal area, r=0.96, p<0.0001, respectively). The mean differences between FD-OCT and IVUS were 0.02±0.17 mm for minimum luminal diameter and 0.42±0.77 mm2 for minimum luminal area, respectively, (figure 1).
Stent malapposition was detectable in all 12 patients (100%) using FD-OCT, but in only 10 patients (83%) using IVUS. The extent of stent malapposition detected with FD-OCT was greater than that detected by IVUS (20% vs 6%, p<0.001, expressed as per cent of total stent surface area; table 3). The maximum distance and maximum area of malapposition detected using FD-OCT were greater than those obtained with IVUS (1.1±0.34 mm vs 0.57±0.32 mm, p<0.001 and 2.65±1.88 mm2 vs 0.88±1.09 mm2, p<0.001, respectively; table 3).
An increase in-stent luminal areas (minimum in-stent luminal area: 8.15±1.90 vs 7.30±1.62 mm2, p<0.05) and a reduction in the extent of stent malapposition (19% vs 34%, p<0.005, expressed as % of total stent surface area) were observed following postdilation when assessed with FD-OCT, but not IVUS (table 4).
This is the first clinical study to examine systematically the utility of FD-OCT and IVUS in the setting of extensive coronary artery calcification. Consistent with published data in more conventional atherosclerotic populations,9 ,10 ,17 FD-OCT generally described smaller lumen dimensions and detected acute stent malapposition more frequently when compared to IVUS. Indeed, acute stent malapposition was detectable to some extent in all patients using FD-OCT, with the amount of stent malapposed ranging from 1% to 53% of the total stent surface area. Finally, high-pressure postdilation with a non-compliant balloon was associated with a significant reduction in acute stent malapposition as detected by FD-OCT.
Our findings that in-stent diameters and luminal areas were smaller with FD-OCT compared to IVUS are largely in keeping with previous clinical studies.9 ,17–20 Moreover, comparing dimensions obtained using FD-OCT with those obtained using IVUS, the mean differences in lumen area observed in this study are consistent with previous work.9 ,10 ,20 The smaller catheter size and faster pullback speed with FD-OCT have been proposed as a potential explanation for these differences.17 However, a recent study by Kubo et al demonstrated that vessel measurements obtained using IVUS overestimated vessel dimensions, while enhanced delineation of the lumen-vessel interface and visualisation of stent struts obtained with FD-OCT led to a more accurate assessment of vessel and stent dimensions.9 This is particularly relevant in heavily calcified vessels where acoustic shadow and reflection may interfere with IVUS assessment (figure 2).6 Consistent with this hypothesis, previous work has demonstrated that vessel dimensions obtained using FD-OCT are highly reproducible10 and more accurate than IVUS.9 ,21 Indeed, in phantom models and in human arteries in vitro, IVUS overestimates vessel luminal area by up to 16% and 14%, respectively,9 ,22 in contrast to QCA measurement of coronary arteries, which underestimates vessel dimensions when compared to FD-OCT.9
In keeping with more accurate delineation of the stent and vessel interface, we found that FD-OCT detected stent malapposition more frequently than IVUS (figure 2). Indeed, following stent deployment but prior to postdilation, stent malapposition was detected in all patients with FD-OCT but in only 83% patients with IVUS. With FD-OCT, the extent of stent malapposition detected (expressed as % of the total stent surface area) ranged from 1% to 53%, compared with 1–21% for IVUS. The extent of malapposition is in keeping the underlying nature of calcific coronary artery disease, where even with the use of ablative procedures such as rotational atherectomy and high-pressure postdilation, stent strut malapposition frequently persists.13 The circumferential extent but not the depth of calcification in the vessel wall as defined by IVUS has previously been shown to predict stent malapposition.23
While the resolution of FD-OCT permits stent strut level analysis,24 this is not the case for IVUS. Previous studies have employed a number of techniques to permit comparison between these two imaging techniques: for example, expressing malapposition as mean malapposed area per cross-sectional slice17 or in binary form as the presence or absence of any stent malapposition.9 More refined methods include an attempt to quantify the extent of malapposition, either as the maximum number of consecutive frames with malapposed struts25 or as the percentage malapposed struts expressed as per cent of total number of struts.26 To address this issue and allow a clinically meaningful comparison between the techniques, we calculated the surface area of the stent that was malapposed and expressed this as a percentage of the total stent surface area. We believe this affords a robust and clinically meaningful method by which to compare stent malapposition as detected using these two techniques.
In this study, postdilation of the implanted stent with a non-compliant balloon inflated to high pressure was associated with a significant increase in the minimal in-stent luminal diameter and area, and a halving in the extent of malapposition observed using FD-OCT. While high-pressure postdilation of coronary stents has yielded mixed outcomes in clinical studies,27–29 our data provide some evidence to support this strategy as routine in patients with extensive coronary calcification where stent malapposition is a frequent finding. Although, mean stent and lumen dimensions obtained using IVUS were numerically greater following postdilation, this did not achieve statistical significance. As discussed above, we believe that this reflects the difficulties in delineating the stent-lumen interface in the presence of extensive vascular calcification.
Our findings suggest that in patients with extensive coronary artery calcification, FD-OCT is superior to IVUS at detecting acute stent underexpansion and malapposition. This, in combination with a more rapid pullback speed (up to 40 mm/s) of FD-OCT resulting in less ischaemic burden,9 and previous data suggesting more accurate assessment of lesion dimensions with FD-OCT, support a clinical utility for FD-OCT in the evaluation of percutaneous coronary intervention in patients with extensive coronary artery calcification. Most of the contemporary data supporting a role for intravascular imaging in this area relate to IVUS30–32 reflecting the temporal evolution of these two technologies. However, in a recent non-randomised case–control study, Prati et al demonstrated a lower incidence of cardiac death and myocardial infarction (6.6% vs 13%, p=0.006) in patients undergoing percutaneous coronary intervention guided by fluoroscopy and FD-OCT compared to fluoroscopic guidance alone.33 Large-scale randomised clinical trials are required before we can be sure our findings with FD-OCT will translate into improved clinical outcomes for patients.
By definition, patients included in this study had undilatable calcific coronary artery lesions preventing delivery of the imaging catheter to the area of interest prior to atherectomy and treatment. This, combined with the need for a rapid intracoronary injection of contrast during FD-OCT imaging and the associated potential for propagation of any atherectomy-induced dissection, meant that intravascular imaging was performed only following rotational atherectomy and stent implantation.
In the current study, reference vessel dimensions were numerically smaller with FD-OCT compared to IVUS but this did not achieve statistical significance, perhaps reflecting the sample size. We elected to pool images obtained following stent implantation with those obtained following postdilation to maximise study power. While we accept this may be a potential source of bias, we believe that the postdilation intervention was sufficient to justify treating each run as a separate data set.
In summary, we have performed a systematic evaluation of the clinical utility of FD-OCT and IVUS in the presence of extensive coronary artery calcification. Our findings suggest that acute stent malapposition occurs frequently in this setting and that FD-OCT affords enhanced stent visualisation and detection of stent malapposition, facilitating stent postdilation and leading to improved stent apposition and minimal luminal areas.
- Received December 1, 2014.
- Revision received April 1, 2015.
- Accepted May 6, 2015.
Contributors IG, PA, NGU and NLC contributed to the conception and design of the study were involved in data acquisition, analysis and interpretation, drafted the manuscript and approved the final version for publication. CG was involved in data analysis and interpretation, contributed to manuscript drafting and approved the final version for publication. JCS, MWB, PH, NM and DEN were involved in data acquisition, contributed to the draft manuscript and approved the final version for publication. All of the authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Funding This work was funded by the Edinburgh and Lothians Health Foundation. NLMC is supported by a National Health Service Research Scotland Career Researcher Award.
Competing interests None declared.
Ethics approval West of Scotland Ethics Committee.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.